WO1994027594A3 - Complexes stables de cuivre(i) et leur utilisation comme substances therapeutiques actives - Google Patents
Complexes stables de cuivre(i) et leur utilisation comme substances therapeutiques actives Download PDFInfo
- Publication number
- WO1994027594A3 WO1994027594A3 PCT/US1994/006247 US9406247W WO9427594A3 WO 1994027594 A3 WO1994027594 A3 WO 1994027594A3 US 9406247 W US9406247 W US 9406247W WO 9427594 A3 WO9427594 A3 WO 9427594A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copper
- agents
- complexes
- stable
- stable copper
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU70517/94A AU7051794A (en) | 1993-06-02 | 1994-06-02 | Stable copper(1) complexes and methods related thereto |
JP7501073A JPH08511006A (ja) | 1993-06-02 | 1994-06-02 | 安定な銅(▲i▼)錯体及びそれに関する方法 |
EP94919342A EP0701439A1 (fr) | 1993-06-02 | 1994-06-02 | Complexes stables de cuivre(i) et leur utilisation comme substances therapeutiques actives |
ZA949336A ZA949336B (en) | 1994-06-02 | 1994-11-24 | Stable copper (I) complexes and methods related thereto. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7144093A | 1993-06-02 | 1993-06-02 | |
US08/071,440 | 1993-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994027594A2 WO1994027594A2 (fr) | 1994-12-08 |
WO1994027594A3 true WO1994027594A3 (fr) | 1995-04-27 |
Family
ID=22101339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1994/006247 WO1994027594A2 (fr) | 1993-06-02 | 1994-06-02 | Complexes stables de cuivre(i) et leur utilisation comme substances therapeutiques actives |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0701439A1 (fr) |
JP (1) | JPH08511006A (fr) |
AU (1) | AU7051794A (fr) |
CA (1) | CA2163640A1 (fr) |
OA (1) | OA10198A (fr) |
TW (1) | TW239077B (fr) |
WO (1) | WO1994027594A2 (fr) |
ZA (1) | ZA943857B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562854B2 (en) | 1994-12-14 | 2003-05-13 | Axys Pharmaceuticals, Inc. | Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders |
WO1996039144A1 (fr) * | 1995-06-06 | 1996-12-12 | Procyte Corporation | Complexes cuivreux stables utilises comme substances a activite therapeutique |
US5637311A (en) * | 1995-06-29 | 1997-06-10 | Procyte Corporation | Zinc(II) complexes and methods related thereto |
US7045531B1 (en) | 1997-03-11 | 2006-05-16 | The General Hospital Corporation | Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator |
US6150379A (en) * | 1997-11-26 | 2000-11-21 | Axys Pharmaceuticals, Inc. | Compounds and compositions as anticoagulants |
US6638711B1 (en) | 1999-04-29 | 2003-10-28 | The General Hospital Corporation | Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation |
WO2005115379A2 (fr) * | 2004-05-24 | 2005-12-08 | New York University | Methode de traitement ou de prevention d'effets pathologiques d'augmentations aigues de l'hyperglycemie et/ou d'augmentations aigues de flux d'acides gras libres |
CA2613297C (fr) * | 2005-06-20 | 2016-12-06 | Dynamiclear Pty Ltd. | Composition pour traiter les lesions cutanees |
CA2933788C (fr) * | 2008-09-03 | 2017-11-28 | Nbc Meshtec, Inc. | Agent antiviral |
US10098857B2 (en) | 2008-10-10 | 2018-10-16 | The Board Of Trustees Of The Leland Stanford Junior University | Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds |
TWI580787B (zh) * | 2012-12-28 | 2017-05-01 | 簡宏堅 | 重組蛋白質、含有該重組蛋白質之醫藥組成物及該重組蛋白質之製備方法 |
WO2019055490A1 (fr) | 2017-09-14 | 2019-03-21 | The Board Of Trustees Of The Leland Stanford Junior University | Conditionnement de tissu irradié pour rétention de greffe de graisse |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6259213A (ja) * | 1985-09-10 | 1987-03-14 | Eisai Co Ltd | ス−パ−オキサイド除去剤 |
US4760051A (en) * | 1985-01-24 | 1988-07-26 | Pickart Loren R | Use of GHL-Cu as a wound-healing and anti-inflammatory agent |
-
1993
- 1993-11-03 TW TW082109174A patent/TW239077B/zh active
-
1994
- 1994-06-02 EP EP94919342A patent/EP0701439A1/fr not_active Withdrawn
- 1994-06-02 CA CA002163640A patent/CA2163640A1/fr not_active Abandoned
- 1994-06-02 AU AU70517/94A patent/AU7051794A/en not_active Abandoned
- 1994-06-02 ZA ZA943857A patent/ZA943857B/xx unknown
- 1994-06-02 WO PCT/US1994/006247 patent/WO1994027594A2/fr not_active Application Discontinuation
- 1994-06-02 JP JP7501073A patent/JPH08511006A/ja active Pending
-
1995
- 1995-12-01 OA OA60750A patent/OA10198A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4760051A (en) * | 1985-01-24 | 1988-07-26 | Pickart Loren R | Use of GHL-Cu as a wound-healing and anti-inflammatory agent |
JPS6259213A (ja) * | 1985-09-10 | 1987-03-14 | Eisai Co Ltd | ス−パ−オキサイド除去剤 |
Non-Patent Citations (6)
Title |
---|
BIJLOO, G. J. ET AL: "Copper complexes of 1,10-phenanthroline and related compounds as superoxide dismutase mimetics", J. INORG. BIOCHEM., 1990, VOL. 40, PAGE(S) 237-44 * |
BROWN DH ET AL: "Antiinflammatory effects of some copper complexes.", J MED CHEM (UNITED STATES), JUL 1980, VOL. 23, NO. 7, PAGE(S) 729-34, * |
DATABASE WPI Week 8716, Derwent World Patents Index; AN 87-112954 * |
DAVIS P.: "Penicillamine metal chelates and their possible importance in rheumatoid arthritis - A brief review", CLIN. INVEST. MED. (ENGLAND), 1984, VOL. 7, NO. 1, PAGE(S) 41-44, * |
GAISSER, H. D. ET AL: "Determination of pKa values of 2,2'-bipyridyl analogs and stability constants of their copper(I) and copper(II) complexes;relationship to antimycoplasmal activity.", EUR. J. MED. CHEM.--CHIM. THER., 1986, VOL. 21, PAGES 285-9 * |
SORENSON J.R.J. ET AL: "Antiulcer activities of D-penicillamine copper complexes", AGENTS ACTIONS (SWITZERLAND), 1982, VOL. 12, NO. 3, PAGE(S) 408-411, * |
Also Published As
Publication number | Publication date |
---|---|
OA10198A (en) | 1996-12-18 |
ZA943857B (en) | 1995-02-01 |
TW239077B (fr) | 1995-01-21 |
EP0701439A1 (fr) | 1996-03-20 |
WO1994027594A2 (fr) | 1994-12-08 |
JPH08511006A (ja) | 1996-11-19 |
AU7051794A (en) | 1994-12-20 |
CA2163640A1 (fr) | 1994-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6985691A (en) | Pharmaceutical and cosmetic compositions | |
CA2234282A1 (fr) | Complexes medicament/resine stabilises par des chelateurs | |
WO1994027594A3 (fr) | Complexes stables de cuivre(i) et leur utilisation comme substances therapeutiques actives | |
GR3018731T3 (en) | Preparation of n-phosphonomethylglycin by oxidation of n-phosphonomethyliminodiacetic acid. | |
AU1874995A (en) | Improved color stability of dental compositions containing metal complexed ascorbic acid | |
TR199902324A3 (tr) | Az çözünen bilesiklerin kararli kompleksleri. | |
EP0992501A3 (fr) | Dérivés d'acide pyridonecarboxylique en tant qu'agent antibactérien | |
WO1995022992A8 (fr) | Procede et compositions permettant de prolonger la demi-vie serique d'agents a activite pharmacologique | |
AU5162796A (en) | Novel peptide derivatives | |
AU2054097A (en) | Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents | |
HK1026909A1 (en) | Substituted phenyl derivatives, their preparation and use | |
AU6972398A (en) | Phosphonic acid derivatives | |
EP0823993A3 (fr) | Microcapsules sensibles au PH. | |
AU9097791A (en) | Phosphonic acid derivatives useful as antiinflammatory agents | |
AU6165196A (en) | Stable formulations of mhc-peptide complexes | |
AU3475393A (en) | Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents | |
AU1064988A (en) | Polymer complexes of metals useful as pharmaceutical agents | |
AU2005888A (en) | Cyclodextrin complexes of bis-biguanido hexane compounds | |
AU648315B2 (en) | The use of macrocyclic aminophosphonic acid complexes as imaging agents | |
AU2136995A (en) | Microbicidal agents based on dibromo-thiophene-carboxylic acid derivatives | |
ZA975755B (en) | Useful formulations of acid addition salt drugs. | |
AU2158799A (en) | Polyrotaxanes | |
FR2703880B1 (fr) | Utilisation de dérivés de l'acide 7-éthynyl alpha-(méthoxy-méthylène) 1-naphtalène acétique pour la préparation de compositions fongicides. | |
AU5635496A (en) | Derivatives of 2,3:4,6-di-o-isopropylidene-alpha-l-xylo-2-he xulofluranosonic acid | |
AU1925501A (en) | Complexes of alkylphosphonic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BB BG BR BY CA CN CZ FI GE HU JP KG KP KR KZ LK LV MD MG MN MW NO NZ PL RO RU SD SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BB BG BR BY CA CN CZ FI GE HU JP KG KP KR KZ LK LV MD MG MN MW NO NZ PL RO RU SD SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2163640 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 267860 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994919342 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994919342 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994919342 Country of ref document: EP |